Abstract
4517 Background: HDC is curative therapy for relapsed GCT. The Beyer model identifies groups with poor (5% EFS at 1-year post-HDC), intermediate (25% EFS), or good risk (≥50% EFS). Given high VEGF ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
